The right drug for the right patient at the right time.''It's a phrase heard often these days as
issues of safety, efficacy, and the cost of health care dominate many discussions on the state …

Ayear ago, in my first letter as president, I outlined SNM's vision for 2007 and 2008 as
working together as a society and alongside our medical colleagues to improve care for all …

Molecular medicine defines the role of genomics and proteomics in personalizing health
care delivery and improving outcomes for patients. Molecular imaging will be one of the …

During our Annual Meeting, SNM sent more than 150 members to Capitol Hill to talk to their
representatives about issues affecting molecular imaging and nuclear medicine. The topics …

SNM's 57th Annual Meeting provided a top-notch educational program, exceptional
networking opportunities, and an attractive destination for more than 5,100 members of the …

For more than a decade, the Centers for Medicare and Medicaid Services (CMS) has been
''bundling''reimbursement for diagnostic radiopharmaceuticals with other costs into one total …

Toronto this month, and this is my last Newsline communication. I want you to know that
SNM remains strong and continues to get stronger. Our membership is growing slowly but …

When I was first asked to run for president of SNM, I agreed. What I didn't realize was that by
the time I became president, SNM would represent not just nuclear medicine but the entire …

Whenever possible, I reiterate my strong belief that our discipline's science and technology
are so powerful that nuclear medicine will continue to play a vital role in patient care and …

It is both an honor and a privilege to step into the role as president of SNM, and I am grateful
for the trust that the society's members have placed in me to continue to represent their …